Home / Deep Research / Southern Tick-Associated Rash Illness

Southern Tick-Associated Rash Illness

Southern Tick-Associated Rash Illness (STARI): Manual Curation Summary

2026-04-16
Manual MONDO:0025294 Model: n/a 7 citations

Southern Tick-Associated Rash Illness (STARI): Manual Curation Summary

Disease framing and lumping/splitting

STARI should be curated as its own lone-star-tick-associated erythema-migrans-like syndrome, not as a subtype of Lyme disease. The strongest comparative clinical study states that an EM-like illness not caused by Borrelia burgdorferi occurs in many southern US states and is known as STARI / Masters disease (PMID:16142659). The 2022 Lyme review likewise treats STARI as one of the principal mimics of early Lyme disease rather than as a geographic Lyme variant (PMID:36116832).

The local MONDO anchor is necessarily imperfect. MONDO issue #9873 requests an exact term for “Southern tick-associated rash illness” with exact synonyms STARI and Masters disease, under the parent MONDO:0025294 tick-borne infectious disease. Until that request is resolved, local curation should use a close match to MONDO:0025294 plus the tracked issue, while NCIT already provides an exact concept (NCIT:C128427 Southern Tick-Associated Rash Illness).

Microbiology and etiology

The core curation point is that the etiologic agent remains unknown.

The foundational 2005 Missouri microbiology study found that neither B. lonestari nor B. burgdorferi was likely to be the cause of the Missouri EM-like lesions; the abstract explicitly concludes that the etiology remains unknown (PMID:15668867). This remains current rather than historical: a 2025 CDC-associated series of 58 STARI patients reported that 16S sequencing detected no known bacterial pathogen and again stated that the etiologic agent remains unknown (PMID:40517644).

This means the dismech entry should not assert an infectious_agent despite the clinical syndrome’s strong tick association and its current placement under a broad MONDO infectious parent.

Mechanism-relevant observations

There is still no confirmed linear disease mechanism. The strongest curation-ready mechanistic observations are:

  1. Unknown cause despite microbiologic workup Multiple cohorts have failed to identify a causative bacterium (PMID:15668867, PMID:40517644).

  2. A. americanum bites are biologically distinct from Lyme transmission Lone star tick saliva is borreliacidal in vitro, with fewer than 13% of exposed B. burgdorferi surviving after 48 hours in one experiment (PMID:15752182). This does not explain STARI, but it strongly supports that A. americanum bites do not simply reproduce classic Lyme transmission biology.

  3. STARI is biochemically distinct from early Lyme disease Human-serum metabolomics differentiated early Lyme disease from STARI with high accuracy and concluded that the two illnesses are metabolically dissimilar (PMID:28814545). This is strong evidence that STARI is a distinct host-response state even though the upstream trigger remains unresolved.

  4. Tick salivary toxins remain a hypothesis, not an established mechanism A 2018 review/case report series proposed that tick salivary toxins may contribute to EM-like rashes and laboratory abnormalities, but this should be captured only as a note-level hypothesis rather than a core pathophysiology claim (PMID:30129909).

Geography and differential with Lyme disease

The geography follows the range of the lone star tick rather than the classic Lyme vectors. The metabolomics study states that STARI occurs where Amblyomma americanum is present, extending from central Texas/Oklahoma through the Midwest and eastward across the southern states and Atlantic coast into Maine, with overlap zones where Lyme disease and STARI are co-prevalent (PMID:28814545).

The 2018 New Jersey review is also useful for curation because it captures the historically reported concentration in southeastern Missouri and several southeastern states while noting east-coast expansion of the vector range (PMID:30129909).

The 2022 review provides the clearest high-level differential diagnosis framing: STARI is a condition causing a similar lesion after a tick bite but of unknown cause (PMID:36116832). This paper is also excellent support for the statement that no laboratory tool exists to diagnose STARI or differentiate it from Lyme disease.

Clinical phenotype and course

The 2005 prospective Missouri versus New York comparison remains the key paper for disease-level phenotype and prognosis claims (PMID:16142659):

  • Missouri patients were less likely to be symptomatic than New York early Lyme patients.
  • Missouri lesions were smaller, more circular, and more likely to have central clearing.
  • Missouri patients were less likely to have multiple lesions.
  • After antibiotic treatment, Missouri patients recovered more rapidly than New York patients.

The metabolomics paper complements this by summarizing the usual mild systemic symptoms: fatigue, fever, headache, and muscle/joint pains in addition to the EM-like lesion (PMID:28814545).

These findings justify modeling STARI as a primarily localized rash-predominant illness with mild constitutional symptoms and a more favorable short-term course than comparator early Lyme disease, while avoiding strong claims about long-term complications because the available abstract-level evidence is limited.

Practical curation takeaways

  • Use a close MONDO match to MONDO:0025294 with tracked issue #9873.
  • Add an exact NCIT mapping to NCIT:C128427.
  • Do not assert a specific infectious agent.
  • Keep the mechanistic story conservative:
  • unknown etiology
  • non-Lyme biologic context of lone star tick bites
  • metabolically distinct from early Lyme disease
  • Use Lyme disease as the primary differential diagnosis.
  • Prefer the 2005 Missouri/New York paper and the 2025 CDC-associated outcomes paper for concise disease-level evidence.

References